Elizabeth Fox,
Elizabeth Fox
Associate Professor of Pediatrics at the Children's Hospital of Philadelphia
Department: Pediatrics
Contact information
,
,
Education:
BS (Laboratory Sciences)
Northeastern University, College of Pharmacy & Allied Health, Boston, MA, 1988.
MD
Pennsylvania State University College of Medicine Hershey, PA, 1993.
MS (Clinical Research)
Duke University College of Medicine Durham, NC, 2006.
Permanent linkBS (Laboratory Sciences)
Northeastern University, College of Pharmacy & Allied Health, Boston, MA, 1988.
MD
Pennsylvania State University College of Medicine Hershey, PA, 1993.
MS (Clinical Research)
Duke University College of Medicine Durham, NC, 2006.
Selected Publications
Kim Aerang, Dombi Eva, Tepas Kathleen, Fox Elizabeth, Martin Staci, Wolters Pamela, Balis Frank M, Jayaprakash Nalini, Turkbey Baris, Muradyan Naira, Choyke Peter L, Reddy Alyssa, Korf Bruce, Widemann Brigitte C: Phase I trial and pharmacokinetic study of sorafenib in children with neurofibromatosis type I and plexiform neurofibromas. Pediatric blood & cancer 60(3): 396-401, Mar 2013.Mossé Yael P, Lipsitz Emily, Fox Elizabeth, Teachey David T, Maris John M, Weigel Brenda, Adamson Peter C, Ingle Mark A, Ahern Charlotte H, Blaney Susan M: Pediatric phase I trial and pharmacokinetic study of MLN8237, an investigational oral selective small-molecule inhibitor of Aurora kinase A: a Children's Oncology Group Phase I Consortium study. Clinical cancer research : an official journal of the American Association for Cancer Research 18(21): 6058-64, Nov 2012.
Chuk Meredith K, Aikin Alberta, Whitcomb Trish, Widemann Brigitte C, Zannikos Peter, Bayever Eliel, Balis Frank M, Fox Elizabeth: A phase I trial and pharmacokinetic study of a 24-hour infusion of trabectedin (Yondelis®, ET-743) in children and adolescents with relapsed or refractory solid tumors. Pediatric blood & cancer 59(5): 865-9, Nov 2012.
Widemann Brigitte C, Kim Aerang, Fox Elizabeth, Baruchel Sylvain, Adamson Peter C, Ingle Ashish M, Glade Bender Julia, Burke Michael, Weigel Brenda, Stempak Diana, Balis Frank M, Blaney Susan M: A phase I trial and pharmacokinetic study of sorafenib in children with refractory solid tumors or leukemias: a Children's Oncology Group Phase I Consortium report. Clinical cancer research : an official journal of the American Association for Cancer Research 18(21): 6011-22, Nov 2012.
Kim AeRang, McCully Cindy, Cruz Rafael, Cole Diane E, Fox Elizabeth, Balis Frank M, Widemann Brigitte C: The plasma and cerebrospinal fluid pharmacokinetics of sorafenib after intravenous administration in non-human primates. Investigational new drugs 30(2): 524-8, Apr 2012.
Lodish Maya, Dagalakis Urania, Chen Clara C, Sinaii Ninet, Whitcomb Patricia, Aikin Alberta, Dombi Eva, Marcus Leigh, Widemann Brigitte, Fox Elizabeth, Chuk Meredith, Balis Frank, Wells Samuel, Stratakis Constantine A: (111)In-octreotide scintigraphy for identification of metastatic medullary thyroid carcinoma in children and adolescents. The Journal of clinical endocrinology and metabolism 97(2): E207-12, Feb 2012.
Marcus Leigh, Murphy Robert, Fox Elizabeth, McCully Cynthia, Cruz Raphael, Warren Katherine E, Meyer Thorsten, McNiff Edward, Balis Frank M, Widemann Brigitte C: The plasma and cerebrospinal fluid pharmacokinetics of the platinum analog satraplatin after intravenous administration in non-human primates. Cancer chemotherapy and pharmacology 69(1): 247-52, Jan 2012.
Balis FM, Fox E. : Challenges of developing new drug for childhood cancer. Clin Invst 2(3): 291-300, 2012.
Fox E, Patel S, Wathen JK, Schuetze S, Chawla S, Harmon D, Reinke D, Chugh R, Benjamin RS, Helman LJ.: Phase II study of sequential gemcitabine followed by docetaxel for recurrent Ewing sarcoma, osteosarcoma, or unresectable or locally recurrent chondrosarcoma: results of Sarcoma Alliance for Research Through Collaboration Study 003. Oncologist 17(3): 321, 2012.
Mosse Y, Balis FM, Lim MS, Laliberte J, Voss S, Fox E, Bagatell R, Weigel B, Adamson PC, Ingle AM, Ahern CH, Blaney S.: Efficacy of crizotinib in children with relapsed/refractory ALK-driven tumors including anaplastic large cell lymphoma and neuroblastoma: A Children's Oncology Group phase I consortium study. American Society of Clinical Oncology, Chicago, IL 2012.